review article

Oman Medical Journal [2015], Vol. 30, No. 1: 3–10

Excessive Daytime Sleepiness and Unintended Sleep Episodes Associated with Parkinson’s Disease Fatai Salawu1* and Abdulfatai Olokoba2

Department of Medicine, Federal Medical Centre, Yola, Nigeria Department of General Internal Medicine, University of Ilorin Teaching Hospital, Ilorin. Nigeria

1 2

A RT I C L E I N F O

Article history: Received: 31 December 2012 Accepted: 7 December 2014 Online: DOI 10.5001/omj.2015.02 Keywords: Parkinson Disease; Sleep; Dopamine Agonists; Pedunculopontine Nucleus.

A B S T R AC T

This article looks at the issues of excessive daytime sleepiness and unintended sleep episodes in patients with Parkinson’s disease (PD) and explores the reasons why patients might suffer from these symptoms, and what steps could be taken to manage them. During the last decade, understanding of sleep/wake regulation has increased. Several brainstem nuclei and their communication pathways in the ascending arousing system through the hypothalamus and thalamus to the cortex play key roles in sleep disorders. Insomnia is the most common sleep disorder in PD patients, and excessive daytime sleepiness is also common. Excessive daytime sleepiness affects up to 50% of PD patients and a growing body of research has established this sleep disturbance as a marker of preclinical and premotor PD. It is a frequent and highly persistent feature in PD, with multifactorial underlying pathophysiology. Both age and disease-related disturbances of sleep-wake regulation contribute to hypersomnia in PD. Treatment with dopamine agonists also contribute to excessive daytime sleepiness. Effective management of sleep disturbances and excessive daytime sleepiness can greatly improve the quality of life for patients with PD.

S

leep disturbances in the late stages of Parkinson’s disease (PD) were recognized by James Parkinson1 in his classic monograph noting that: “The sleep becomes much disturbed. The tremulous motions of the limbs occur during sleep, and augment until they awaken the patient, and frequently with much agitation and alarm…..and at the last, constant sleepiness, with slight delirium”. The diagnosis of PD requires the identification of its cardinal features, which are motor symptoms. Diagnosis is impossible without them, but recognition of the importance of nonmotor features has increased over the past years.2 Non-motor features (which include autonomic nervous system dysfunction, disorders of cognition and mood, psychosis, pain, loss of smell, and fatigue) affect nearly all PD patients, appear early in the course of PD, and contribute to excessive daytime sleepiness (EDS). All of these symptoms have significant adverse effects on the quality of life (QoL) of both patients and caregivers and require proper identification and treatment.3-7

Clinical presentation of sleep disturbance

Sleep-related problems in PD can be divided into disturbances of sleep and disturbances of wakefulness. Disturbances of sleep include insomnia,

*Corresponding author:  [email protected]

restless leg syndrome (RLS), rapid eye movement sleep behavior disorder (RBD), sleep apnea, and parasomnias. Disturbances of wakefulness include EDS, and sleep attacks. With normal aging, there is disruption of normal sleep architecture and alterations in the normal circadian rhythm leading to impaired nocturnal sleep and EDS.8,9 These problems are accentuated in PD patients, with 60% to 90% having some form of sleep disturbance, particularly in the advanced stages of the disease.3,6,10-12

Epidemiology of sleep disturbance in Parkison’s disease

The prevalence of sleep disturbance in PD is difficult to ascertain due to the heterogeneity of patients and different criteria used to categorize sleep disturbances. There is paucity of data on the role of gender in sleep disturbances. Smith and colleagues,13 studied 153 patients and their spouses, and reported that sleep disturbances occurred more frequently in females with PD (41%) than in men (25%). However, there was no sex difference for difficulty initiating sleep. Van Hilten and colleagues,14 observed that female patients experienced more difficulty maintaining sleep (87.5%) and excessive dreaming (68.4%) than males (64% and 31.6%, respectively). Sleep dysfunction in PD usually manifests by difficulty

4

Fatai Sal awu, et al.

in initiating sleep, fragmented sleep, reversal of the sleep cycle, and EDS.15,16 EDS was assessed using the Epworth scale in 101 patients with PD and 100 age-matched controls.17 EDS was detected in 76% of patients with PD compared to 47% of controls (p

Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

This article looks at the issues of excessive daytime sleepiness and unintended sleep episodes in patients with Parkinson's disease (PD) and explores ...
825KB Sizes 3 Downloads 28 Views

Recommend Documents


Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat.
Obstructive sleep apnea (OSA) is associated with an increased risk of obesity and non-alcoholic fatty liver disease (NAFLD), but it remains unclear whether the risk of NAFLD is independently related to OSA regardless of visceral obesity. Thus, the ai

Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.
Diurnal fluctuations of motor and nonmotor symptoms and a high prevalence of sleep-wake disturbances in Parkinson disease (PD) suggest a role of the circadian system in the modulation of these symptoms. However, surprisingly little is known regarding

Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease.
The multimodal imaging investigation of excessive daytime sleepiness (EDS) in Parkinson's disease (PD). The role of dopaminergic treatment and other clinical parameters was also evaluated.

Is excessive daytime sleepiness a separate manifestation in Parkinson's disease?
Excessive daytime sleepiness (EDS) is common in Parkinson's disease (PD), but its role and relation to other PD features is less well understood.

Development of excessive daytime sleepiness in early Parkinson disease.
To examine the frequency, development, and risk factors of excessive daytime sleepiness (EDS) in a cohort of originally drug-naive patients with incident Parkinson disease (PD) during the first 5 years after diagnosis.

Habitual Sleep Duration, Unmet Sleep Need, and Excessive Daytime Sleepiness in Korean Adults.
Sleep need differs between individuals, and so the same duration of sleep will lead to sleep insufficiency in some individuals but not others. The aim of this study was to determine the separate and combined associations of both sleep duration and un

Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing.
To determine the incidence of positive drug screens in children undergoing a multiple sleep latency test (MSLT) for evaluation of excessive daytime sleepiness (EDS).